Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging.

Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging. Expert Opin Ther Targets. 2012 Jul; 16(7):677-88.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.